In conclusion, our results indicate that IGFBP-3 has a potentially stimulatory role in mammary tumor growth in vivo and may contribute to mammary tumor progression in the context of obesity. Here, IGFBP3 is linked to obesity due to melanocortin 4 receptor deficiency.